Extreme Movers: Claude Sonnet 5.5's picks for 2026-09-30

Claude Sonnet 5.5 picked CCL, IOVA, DKNG, FICO, BE for a 1-day horizon. Average directional return: +2.16%. Directions called correctly: 80%.

ExperimentExtreme Movers
ModelClaude Sonnet 5.5
Prompt versionextreme-movers-v11
Asked
Horizon1-day
Measured from2026-09-30
Measured to2026-10-01
BenchmarkSPY
StatusSettled
Average directional return+2.16%
Directions called correctly80%
Benchmark return-0.99%

The picks

RankSymbolDirectionPrice changeReturn in the called directionConfidencevs benchmarkCalled right
1CCLup-2.30%-2.30%55%-1.31%No
2IOVAup+1.29%+1.29%50%+2.28%Yes
3DKNGdown-2.67%+2.67%48%+3.66%Yes
4FICOup+6.49%+6.49%42%+7.48%Yes
5BEdown-2.69%+2.69%40%+3.68%Yes

The model's market view

The source session was Tuesday 2026-09-29. Stocks were mixed with the 10-year Treasury yield near 5.29% and the 30-year near 5.6%, which is a headwind for long-duration names. Earnings and news-driven movers stood out: Carnival, Iovance and Bloom Energy on the upside, Fair Isaac and DraftKings on the downside. I could not reach a live 2026-09-30 intraday quote for any pick, so every reference_price is the 2026-09-29 regular-session close. That is about one session stale as of this answer. Micron reports after the close on 2026-09-30, and PCE inflation and jobs data are due this week, so the AI and yield trades could move sharply. Avg_dollar_volume_20d_usd is omitted for all five picks because I could not verify a 20-day average dollar volume from any source I reached.

Why each pick

CCL

Source-session change was +13.4% (close $25.11), so up with continuation means direction up. The catalyst looks substantive: Q3 adjusted EPS of $1.43 beat the $1.35-1.36 consensus, revenue of $8.44B beat estimates, full-year EPS guidance was raised, and 2027 bookings and pricing are at record levels. Post-earnings drift and a low valuation multiple favor further upside. The main risks are fuel prices, geopolitical tensions, and rising yields hitting consumer discretionary names. Price is the 2026-09-29 regular-session close, about one session stale. Market cap and 20-day average dollar volume are omitted because I could not verify them, although the company is clearly large and liquid.

IOVA

Source-session change was +31.48% (close $14.45, new 52-week high), so up with continuation means direction up. The catalyst is substantive: the company raised 2026 revenue guidance to $410-420M from $350-370M, above the roughly $403M consensus, and TD Cowen lifted its price target to $16 from $10. Analyst target raises and post-guidance drift support follow-through. The risk is high: after a 30%+ one-day jump, biotech names often see profit-taking, and it is a high-short-interest name. Price is the 2026-09-29 close, about one session stale. Market cap and 20-day average dollar volume could not be verified and are omitted.

DKNG

Source-session change was -7.42% (close $19.59, a new 52-week low), so down with continuation means direction down. The move looks more speculative and sentiment-driven than substantive: sympathy with Flutter after Brazil's online betting ban, a congressional probe into prediction markets, and concern about heavy prediction-market spending. The stock is well below its 50-day and 200-day moving averages, with a death cross in place. The risk is an oversold bounce, and the appeals-court ruling that sports bets are not swaps is a positive. Price is the 2026-09-29 close. Market cap was reported as just under $10B by one source. I did not record an exact figure, so market cap and 20-day average dollar volume are omitted as unconfirmed.

FICO

Source-session change was -26.52% (close $617.87), so up with reversal means direction up. The catalyst is substantive: the FHFA director announced a single Fannie/Freddie pricing grid that puts VantageScore alongside FICO Classic, and TransUnion locked in $0.99 VantageScore pricing through 2028. That threatens FICO's mortgage pricing power. I am betting on an oversold bounce after the worst one-day drop in over two years, with a 3-year low, a consensus target around $1,400, and analyst defenses. The risk is high: this is structural, Barclays cut its target to $935, and Huber downgraded to Underweight. A second down day is very possible, and one page quoted a lower price of $614 that I could not tie to a timestamp. Market cap of about $13.35B is derived from 21.60M shares outstanding (CNBC quote page) times the $617.87 close. It is not a directly quoted figure. 20-day average dollar volume could not be verified and is omitted. Price is the 2026-09-29 close.

BE

Source-session change was +11.21% (close $292.34), so down with reversal means direction down. The catalyst leans speculative: a Jefferies price-target raise to $264 (below the stock price, with a Hold rating) plus Oracle reaffirming a project, riding AI power-demand enthusiasm. It was the only double-digit gainer in a 383-name priority list. The stock traded above $300 intraday, so a fade from the highs is plausible. Yields are at multi-decade highs, and Micron reports after the close on 2026-09-30, which could swing AI-linked names either way. The risk is that AI momentum continues and squeezes a short position. Price is the 2026-09-29 close, about one session stale. Market cap and 20-day average dollar volume could not be verified and are omitted.

Other models on the same run

ModelPicksAverage directional returnDirections called correctly
PerplexityFORM, HPE, MRNA, CEG, APP-0.85%40%
Grok 4.5CCL, BE, FICO, RCL, STLD-0.10%20%
DeepSeekCCL, FICO, IOVA, LITE, RCL+0.15%40%
Muse Spark 1.1IOVA, BE, CCL, FICO, QURE+0.35%60%
Gemini 1.5 ProCCL, FICO, BE, RCL, IOVA-1.26%40%
GPT-6IOVA, FICO, CCL, BE, KMX-0.26%60%

Written up on ForecastNest Insights: Extreme Movers: Claude Sonnet 5.5's picks for 2026-09-30.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.